А. П. Лыков

981 total citations
91 papers, 335 citations indexed

About

А. П. Лыков is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, А. П. Лыков has authored 91 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 20 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in А. П. Лыков's work include Mesenchymal stem cell research (22 papers), Cancer Cells and Metastasis (12 papers) and Electrospun Nanofibers in Biomedical Applications (10 papers). А. П. Лыков is often cited by papers focused on Mesenchymal stem cell research (22 papers), Cancer Cells and Metastasis (12 papers) and Electrospun Nanofibers in Biomedical Applications (10 papers). А. П. Лыков collaborates with scholars based in Russia, United States and Slovakia. А. П. Лыков's co-authors include О. В. Повещенко, В. И. Коненков, Н. П. Бгатова, Vadim V. Klimontov, А. Ф. Повещенко, Evgeny Pokushalov, Т. А. Короленко, Thomas P. Johnston, Andreas Pfeiffer and Н. В. Гончарова and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

А. П. Лыков

79 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. П. Лыков Russia 11 75 60 54 41 35 91 335
Fatma Y. Meligy Egypt 9 114 1.5× 56 0.9× 65 1.2× 19 0.5× 27 0.8× 25 359
Liang Luo China 8 84 1.1× 33 0.6× 56 1.0× 33 0.8× 29 0.8× 35 398
Shuo Geng China 11 105 1.4× 42 0.7× 43 0.8× 41 1.0× 50 1.4× 20 419
Shumin Zhang China 11 115 1.5× 46 0.8× 56 1.0× 18 0.4× 56 1.6× 34 438
Huina Zhang China 11 93 1.2× 41 0.7× 60 1.1× 24 0.6× 38 1.1× 24 407
Kun Fu China 13 126 1.7× 35 0.6× 47 0.9× 25 0.6× 15 0.4× 27 375
Parisa Kangari Iran 6 163 2.2× 83 1.4× 58 1.1× 19 0.5× 34 1.0× 9 432
Yu Qi China 10 153 2.0× 63 1.1× 46 0.9× 35 0.9× 19 0.5× 19 383
Guoliang Yan China 12 131 1.7× 34 0.6× 104 1.9× 27 0.7× 24 0.7× 41 410
Xingtong Wang China 10 109 1.5× 24 0.4× 56 1.0× 41 1.0× 53 1.5× 45 388

Countries citing papers authored by А. П. Лыков

Since Specialization
Citations

This map shows the geographic impact of А. П. Лыков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. П. Лыков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. П. Лыков more than expected).

Fields of papers citing papers by А. П. Лыков

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. П. Лыков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. П. Лыков. The network helps show where А. П. Лыков may publish in the future.

Co-authorship network of co-authors of А. П. Лыков

This figure shows the co-authorship network connecting the top 25 collaborators of А. П. Лыков. A scholar is included among the top collaborators of А. П. Лыков based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. П. Лыков. А. П. Лыков is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surovtsev, N. V., et al.. (2024). Reversed Corneal Fibroblasts Therapy Restores Transparency of Mouse Cornea after Injury. International Journal of Molecular Sciences. 25(13). 7053–7053. 2 indexed citations
2.
Лыков, А. П.. (2023). Mesenchymal stem cells: properties and clinical application. SHILAP Revista de lepidopterología. 43(2). 40–53. 1 indexed citations
4.
Лыков, А. П., et al.. (2023). Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue Engineering. International Journal of Molecular Sciences. 24(10). 8828–8828. 2 indexed citations
5.
Лыков, А. П., et al.. (2021). Bioavailability and Safety of Lipid Fraction from Different Taxa of Microalgae in Female C57BL/6 Mice. Biointerface Research in Applied Chemistry. 12(5). 6845–6862.
6.
Лыков, А. П., et al.. (2021). Platelet Lysate and Non-Healing Ulcers. Biointerface Research in Applied Chemistry. 11(4). 12267–12274. 2 indexed citations
7.
Лыков, А. П., et al.. (2020). Erythropoietin and Mesenchymal Stem Cells Properties. Biointerface Research in Applied Chemistry. 10(5). 6197–6207. 2 indexed citations
8.
Лыков, А. П., et al.. (2020). In Vitro and In Vivo Effect of the Composition of Fucoxanthin with Porous Aluminum-Silicon Career on Cells. Biointerface Research in Applied Chemistry. 11(2). 9467–9476. 2 indexed citations
9.
Лыков, А. П., et al.. (2020). Effect of erythropoietin on bone marrow mononuclear cells. SHILAP Revista de lepidopterología. 22(1). 135–142. 4 indexed citations
10.
Лыков, А. П., et al.. (2019). EFFECT OF ERYTHROPOIETIN ON CYTOKINE PRODUCTION BY STEM CELLS. SHILAP Revista de lepidopterología. 21(5). 861–868. 3 indexed citations
11.
Лыков, А. П., et al.. (2019). Tumor-associated mesenchymal stem cells in chemically-induced breast cancer in Wistar rats. SHILAP Revista de lepidopterología. 18(1). 56–64. 1 indexed citations
12.
Лыков, А. П., et al.. (2018). Phenotype of bone-marrow mononuclear cells before and after short-time precondition with erythropoietin from patients with ischemic heart failure. Russian Open Medical Journal. 7(2). e0202–e0202. 3 indexed citations
13.
Klimontov, Vadim V., et al.. (2018). Insulin-induced lipohypertrophy: clinical and ultrasound characteristics. Diabetes Mellitus. 21(4). 255–263. 4 indexed citations
14.
Klimontov, Vadim V., et al.. (2018). Insulin-induced lipohypertrophy: clinical and ultrasound characteristics. Diabetes Mellitus. 21(4). 255–263. 2 indexed citations
15.
Лыков, А. П., et al.. (2018). Autologous Plasma Enriched with Platelet Lysate for the Treatment of Idiopathic Age-Related Macular Degeneration: A Prospective Study. Annals of the Russian academy of medical sciences. 73(1). 40–48. 2 indexed citations
16.
Лыков, А. П., et al.. (2017). STEM/PROGENITOR CELLS ADHESION STRENGTHENING TO SYNTHETIC MATERIAL USING EXTRACELLULAR MATRIX. Annals of the Russian academy of medical sciences. 72(5). 336–345. 1 indexed citations
17.
Лыков, А. П., et al.. (2017). Levels of miRNA and Hormones in Thoracic Duct Lymph in Rats with Experimental Breast Cancer Induced by N-Methyl-N-Nitrosourea. Bulletin of Experimental Biology and Medicine. 162(3). 387–390. 2 indexed citations
18.
Лыков, А. П., et al.. (2017). Comparative Effects of Platelet-Rich Plasma, Platelet Lysate, and Fetal Calf Serum on Mesenchymal Stem Cells. Bulletin of Experimental Biology and Medicine. 163(6). 757–760. 13 indexed citations
19.
Повещенко, О. В., et al.. (2016). Development and in vitro study on tissue engineered structures based on polytetrafluoroethylene and multipotent mesenchymal stromal cells. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Лыков, А. П., et al.. (2016). LEVELS OF HORMONES, microRNA AND CYTOKINES IN LYMPH FROM HEALTHY AND EXPERIMENTAL BREAST CANCER. Siberian Journal of Oncology. 15(5). 33–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026